期刊
ANTIOXIDANTS & REDOX SIGNALING
卷 13, 期 3, 页码 279-347出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2009.2788
关键词
-
资金
- National Institutes of Health [HL089514, HL073246, 2PO1AG15885]
- VA Research Merit Award [8204-05P]
- American Heart Association [0855940G]
- office of Research Development, Medical Research Service, Department of Veteran Affairs
- [HL094317]
The mitochondrion is the most important organelle in determining continued cell survival and cell death. Mitochondrial dysfunction leads to many human maladies, including cardiovascular diseases, neurodegenerative disease, and cancer. These mitochondria-related pathologies range from early infancy to senescence. The central premise of this review is that if mitochondrial abnormalities contribute to the pathological state, alleviating the mitochondrial dysfunction would contribute to attenuating the severity or progression of the disease. Therefore, this review will examine the role of mitochondria in the etiology and progression of several diseases and explore potential therapeutic benefits of targeting mitochondria in mitigating the disease processes. Indeed, recent advances in mitochondrial biology have led to selective targeting of drugs designed to modulate and manipulate mitochondrial function and genomics for therapeutic benefit. These approaches to treat mitochondrial dysfunction rationally could lead to selective protection of cells in different tissues and various disease states. However, most of these approaches are in their infancy. Antioxid. Redox Signal. 13, 279-347.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据